Ken Research Latest report on “
India
Pediatric Drugs and Vaccines Market Outlook to 2021– Rise in prevalence
of chronic diseases and inclusion of several new vaccines in national
immunization programme to Shape Future Growth” provides a
comprehensive analysis of the pediatric drugs and vaccines market in
India and covers market size and segmentation of overall market by drugs
and vaccines. The report covers the further segmentations of different
spaces such as Drugs and Vaccines into sub segments based on their
individual characteristics. The sub segments of Drugs (Patented and
Generic, Treatment and Management, Drug Classes, Prescription and OTC,
Online and Offline) are then considered separately and analysis on them
has been done individually. Similarly, the sub segments of Vaccines
(Monovalent and Multivalent, Technology, Indication) have also been
considered. The report covers detailed profiles of leading players in
the different sub segments in the market. The potential and future
outlook has been individually discussed for India Pediatric Drug and
Vaccine market. The report provides detailed analysis of segments,
trends & developments, growth drivers and major restraints and
challenges within the industry. The report also serves as a benchmark
for existing players and for new players who wish to capitalize on the
market potential and investors who are looking forward to venture into
pediatric drugs and vaccines market in India.
India Pediatric Drugs Market
India
is a home of the largest pediatric population of the world and also has
the highest number of annual child births in the world. However, almost
~% of the medicines used in children presently has never been studied
for their efficacy in pediatric population. The pediatric drugs market
in India grew at a staggering CAGR of ~% during the period
FY’2011-FY’2016 exhibiting the annual revenue of INR ~ billion in
FY’2011 which inclined to INR ~ billion in FY’2016. Owing to an
astounding number of births in the country, the pediatric drugs market
has showcased growth at a faster pace than the overall pharmaceutical
market of the country during the concerned period.
Segmentation
By Product Type (Patented and Generic): The
market for pediatric drugs and vaccines in India is entirely driven by
companies manufacturing generic drug formulations. Almost all
pharmaceutical companies operating in the country have expertise in
developing generic drugs so as to cater to the underprivileged
population at a much cheaper price. Generic drug therefore comprised
almost ~% of the market share as of FY’2016 whereas patented drugs
accounted for ~% market share.
By Usage (Treatment and Management): A
large part of drugs sold in the country is meant for the treatment of
several infectious and non-infectious diseases prevalent in the
pediatric population. Pediatric drugs are most commonly used for
diarrheal diseases such as cholera and viral gastroenteritis. Owing to
less prevalence of lifestyle diseases amongst pediatric population,
market share of drugs meant for management of diseases has been low.
Drugs meant for management of diseases accounted for ~% market share as
compared to ~% for treatment of diseases.
By Drug Classes (Anti-Infectives, Antihistamines, Cardiovascular Drugs and Others): Anti-infectives
were the most frequently prescribed drug class by pediatricians, with
over ~% of the prescriptions had some form of prescribed antibiotics.
This was due to wide scale prevalence of respiratory diseases among
children. Anti-infectives accounted for a market share of ~% as of
FY’2016 as compared to anti-histamines (~%), cardiovascular drugs (~%)
and all other (~%) categories of drugs.
By Procurement Method (Prescription and OTC): In
India, parents always consult a doctor for their children’s illness and
therefore only buy drugs that are prescribed by a healthcare
professional. Scenario is same in both rural and urban areas as parents
are very conscious about children’s well being and are not willing to
rely on OTC drugs without proper knowledge and supervision. Prescription
drugs therefore contributed to around ~% in market share as compared to
~% by OTC drug as of FY’2016.
By Distribution Channel (Online and Offline): Currently,
procurement of pediatric drugs is almost entirely done through offline
medium from hospital pharmacies, retail pharmacies, doctors or
institutional health centers. Since the requirement of drugs is usually
on an urgent basis, parents don’t prefer placing an order online and
receive it a later date. As a result, offline sales of drugs accounted
for almost ~% of the drug sales as compared to ~% by online medium.
India Pediatric Vaccines Market
India
has emerged as the leading vaccine producer in the world, in terms of
doses of vaccines produced. The country has ~ major vaccine
manufacturing facilities across the country as of FY’2016. Vaccines
manufactured in these facilities are offered in both national and
international market (over 150 countries). More than ~% of all measles
vaccines used globally are produced in India.
The Indian pediatric
market for vaccines has grown at a remarkable CAGR of ~% during the
period FY’2011-FY’2016. The growth was attributed to some crucial
vaccines (polio, hepatitis B, MMR and BCG) manufactured by Indian
companies constantly featured in WHO’s prequalified list coupled with
the fact that Indian companies (Serum Institute of India, Bharat
Biotech, Panacea Biotec) acted as major suppliers of vaccines to WHO,
UNICEF, PATH and other UN agencies. The market for pediatric vaccines
grew from INR ~ billion in FY’2011 to INR ~ billion in FY’2016.
Segmentation
By Type of Vaccine A
large chunk of vaccines administered under the national immunization
programme in the country are of the monovalent form. Monovalent vaccines
therefore comprised for a market share of ~% as compared to ~% by
multivalent forms.
By Technology: Inactivated
vaccines were the earliest forms of vaccines developed by scientists and
continue to be widely used in the country. Killed or inactivated
vaccine comprised a market share of ~% as compared to ~% by live or
attenuated, ~% by toxoid vaccines, ~% by subunit forms, ~% by conjugate
vaccines and remaining ~% by all other forms.
Key Topics Covered in the Report:
- Value Chain Analysis of India Pediatric Drugs and Vaccine Market
- India Pediatric Drugs and Vaccine Market by Value, FY’2011-FY’2016
- India Pediatric Drugs Market Introduction and Size, FY’2011-FY’2016
- India
Pediatric Drugs Market Segmentation by Product Type (Patented and
Generic), by Usage (Treatment and Management), by Drug Classes
(Anti-infectives, Antihistamines, Cardiovascular drugs and Others), by
Procurement Method (Prescription and OTC), by Distribution Channel
(Offline and Online), FY’2016
- Competitive Landscape of Major Players in India Pediatric Drugs Market
- India Pediatric Drugs Future Market Outlook, FY’2017-FY’2021
- India Pediatric Vaccines Market introduction and Size, FY’2011-FY’2016
- India
Pediatric Vaccines Market Segmentation by Vaccine Type (Monovalent and
Multivalent), by Technology (Live or attenuated, Killed or inactivated,
Toxoid, Conjugate, Subunit and Others), by Indication (Polio, MMR, DTP,
Hepatitis B, Influenza, BCG and Others), FY’2016
- Competitive Landscape of Major Players in India Pediatric Vaccines Market
- Pipeline Analysis of Global and India Pediatric Vaccine Market
- India Pediatric Vaccines Future Market Outlook, FY’2017-FY’2021
- Vaccines Market Growth India
- Drug Information Dosage Side Effects,
- Pediatric Vaccine Serum Institute of India
- New Drug Launches India Pharma Sector
- Number of Pediatrician Statistics
- Pediatric tuberculosis drug Market
- Drug Pipeline Pediatric Drug,
- Vaccine Clinical Trials India
For more information about the publication, refer to below link:
https://www.kenresearch.com/healthcare/pharmaceuticals/india-pediatric-drug-vaccine-market/81319-91.html
Related Reports:
Global Glaucoma Treatment Drugs Market Forecast to 2020 - New Product Launches Expected to Boost Market
US
Aesthetic Lasers and Energy Devices Market Outlook to 2020 - Aging
Population and High Prevalence Rate of Obesity to Foster Future Growth
Qatar
Wellness Market Outlook to 2020 - Rising Awareness about health &
Fitness and Prevalence in Lifestyle Diseases will drive the Market
Contact Us: Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com +91-9015378249
